HYPD
NASDAQ · Pharmaceuticals
Hyperion Defi Inc
$2.75
+0.08 (+3.00%)
Open$2.67
Previous Close$2.67
Day High$2.75
Day Low$2.65
52W High$15.00
52W Low$2.34
Volume—
Avg Volume241.8K
Market Cap40.70M
P/E Ratio—
EPS$-3.92
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+486.9% upside
Current
$2.75
$2.75
Target
$16.14
$16.14
$9.68
$16.14 avg
$20.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.41M | 4.90M | 5.01M |
| Net Income | -134,117,261 | -3,832,248,999 | 1.46M |
| Profit Margin | -5,570.6% | -82,538.4% | 29.2% |
| EBITDA | -131,332,000 | -3,873,168,857 | 1.99M |
| Free Cash Flow | — | — | 1.60M |
| Rev Growth | — | -84.0% | +22.0% |
| Debt/Equity | 0.19 | 1.59 | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |